LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.43 | 84.90 | 849 | 3459 | 0.2454 | 0.5380 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.43 | 84.90 | 484 | 3459 | 0.1399 | 0.3846 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.43 | 84.90 | 862 | 3459 | 0.2492 | 0.5424 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 40.14 | 84.90 | 564 | 3682 | 0.1532 | 0.4165 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 40.14 | 84.90 | 837 | 3682 | 0.2273 | 0.5231 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 40.14 | 84.90 | 494 | 3682 | 0.1342 | 0.3824 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 40.14 | 84.90 | 865 | 3682 | 0.2349 | 0.5324 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.84 | 84.90 | 556 | 4003 | 0.1389 | 0.4022 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.84 | 84.90 | 814 | 4003 | 0.2033 | 0.5017 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.84 | 84.90 | 428 | 4003 | 0.1069 | 0.3378 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.84 | 84.90 | 857 | 4003 | 0.2141 | 0.5157 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.55 | 84.90 | 500 | 4287 | 0.1166 | 0.3680 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.55 | 84.90 | 823 | 4287 | 0.1919 | 0.4940 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.55 | 84.90 | 367 | 4287 | 0.0856 | 0.2953 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.55 | 84.90 | 841 | 4287 | 0.1961 | 0.4997 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.25 | 84.90 | 476 | 4539 | 0.1049 | 0.3503 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.25 | 84.90 | 826 | 4539 | 0.1819 | 0.4863 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.25 | 84.90 | 355 | 4539 | 0.0782 | 0.2830 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.25 | 84.90 | 854 | 4539 | 0.1881 | 0.4950 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.95 | 84.90 | 363 | 4952 | 0.0733 | 0.2811 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.95 | 84.90 | 794 | 4952 | 0.1603 | 0.4639 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.95 | 84.90 | 301 | 4952 | 0.0608 | 0.2408 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.95 | 84.90 | 840 | 4952 | 0.1696 | 0.4780 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.65 | 84.90 | 297 | 5328 | 0.0557 | 0.2333 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.65 | 84.90 | 800 | 5328 | 0.1501 | 0.4559 | MN20160318_Q02 | F05 |